Mobile Intervention for Simultaneous Alcohol and Marijuana Use in Young Adults
Launched by KAISER PERMANENTE · Aug 7, 2023
Trial Information
Current as of August 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at ways to help young adults who use both alcohol and marijuana at the same time. The researchers want to develop a mobile program that uses techniques to help these individuals manage their cravings and reduce negative outcomes from their substance use. They will test different strategies to find out which ones work best. The study will take place in Honolulu, Hawaii, and will involve 136 young adults aged 18 to 30 who currently use both substances. Participants will be organized into different groups to see which intervention methods are most effective in improving their experiences and reducing harmful effects.
To be eligible for this study, participants must live on the island of O'ahu, have used alcohol and marijuana recently, and have experienced some negative consequences from their use. They also need to feel confident in their ability to use strategies that can help them make safer choices. Participants should own a smartphone, as the intervention will be delivered through a mobile app. Throughout the study, individuals will participate in follow-up assessments to see how well the strategies work for them. It's an opportunity to potentially benefit from new approaches to managing substance use in a supportive setting.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • resident of state of Hawai'i and island of O'ahu
- • age 18-30 years
- • has sought services at Kaiser Permanente Hawaii within the past year
- • report marijuana use, heavy drinking, and simultaneous alcohol and marijuana use
- • report confidence in ability to use protective behavioral strategies
- • endorse at least 3 recent negative consequences from marijuana and/or alcohol
- • own a smartphone
- Exclusion Criteria:
- • • any substance use treatment within the past 3 months
About Kaiser Permanente
Kaiser Permanente is a leading integrated health care organization that combines a health plan with a network of hospitals and physicians to provide comprehensive medical services. With a strong commitment to advancing medical research and improving patient care, Kaiser Permanente sponsors clinical trials across various therapeutic areas. The organization emphasizes innovative approaches to health care, leveraging its extensive data and resources to support evidence-based treatments and enhance patient outcomes. Through its rigorous research initiatives, Kaiser Permanente aims to contribute to the advancement of medical knowledge and the development of new therapies that benefit diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Honolulu, Hawaii, United States
Patients applied
Trial Officials
Kristina Phillips, PhD
Principal Investigator
Kaiser Permanente
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported